Gentamicin
Active ingredient · 5 therapeutic classes
- Drug class
- Other Aminoglycosides
- Availability
- Prescription only
- Routes
- Intramuscular, Ophthalmic, Intravenous, Topical
- Markets covered
- 3
- Products on record
- 32
Overview
Plain-language summary, compiled from the cited regulatory records
Gentamicin is an antibiotic used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria [1]. It belongs to the drug class of other antibiotics for topical use [1].
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Injection, USP and other antibacterial drugs, it should only be used when necessary [1]. When information on culture and susceptibility is available, it should be considered when selecting or changing antibacterial therapy [1]. In the absence of such data, local epidemiological factors should guide the choice of treatment [1].
This medication is available under various brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 21 | April 10, 2026 |
| CA Canada | Health Canada | 7 | January 29, 2026 |
| US United States | FDA | 4 | February 3, 2025 |
GBUnited Kingdom· MHRA
21 products
Uses
Gentamicin is an aminoglycoside antibiotic with broad-spectrum bactericidal activity. , Proteus spp. , Citrobacter spp. and Providencia spp. Consideration should be given to official local guidance on the appropriate use of antibacterial agents.
How to take
CACanada· Health Canada
7 products
Uses
Gentamicin Injection USP (gentamicin sulfate) is clinically effective in serious infections caused by susceptible strains of the following bacteria: Pseudomonas aeruginosa, Proteus species (indole negative and indole positive), Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Serratia marcescens, and Staphylococcus species (methicillin-susceptible strains only).
Gentamicin Injection USP (gentamicin sulfate) may be considered for the treatment of Staphylococcus infections when other less potentially toxic drugs are contraindicated and bacterial susceptibility tests and clinical judgment indicate its use.
The use of gentamicin is indicated in the treatment of serious infections caused by laboratory determined susceptible bacteria, with due regard for relative antibiotic toxicity. Therefore, the drug should be considered for treatment of: Bacteremia Respiratory tract infections Urinary tract infections Infected wounds: surgical and traumatic Bone and soft tissue infections, including peritonitis and burns complicated by sepsis In the majority of cases bacteriologic cultures should be obtained initially to identify the causative organism(s) and to determine susceptibility to gentamicin.
USUnited States· FDA
4 products
Uses
INDICATIONS AND USAGE
Gentamicin sulfate ophthalmic solution is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.
How to take
Drug interactions
Known interactions involving Gentamicin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 264. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL127620681 · revised April 10, 2026
- [2]Health Canada (DPD) · 02457008 · revised March 22, 2025
- [3]FDA DailyMed · 0bef2a01-69d0-cf… · revised February 3, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.